Indications |
Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: Apply a thin layer of 0.02-0.05% cream, gel, oint over affected areas as directed. |
Contraindications |
Infectious dermatoses. |
Warnings / Precautions |
Glaucoma, infection. Avoid applying to broken skin or under occlusive dressings to prevent systemic absorption effects. |
Adverse Reactions |
Skin thinning when applied under occlusion. Folliculitis, hypertrichosis, skin atrophy, superinfection, stretch mark, loss of skin collagen and SC atrophy, local depigmentation, acne, burning sensation, pruritus, chronic glaucoma. Telangiectasia and purpura. |
Mechanism of Actions |
Difluprednate is a topical corticosteroid with glucocorticoid activity. It exhibits anti-inflammatory and immunosuppressive effects by inhibiting the release of various cytokines. |
ATC Classification |
D07AC19 - difluprednate ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases. |
Available As |
|
Difluprednate
Post Review about Difluprednate Click here to cancel reply.
Difluprednate Containing Brands
Difluprednate is used in following diseases
Drug - Drug Interactions of Difluprednate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.